{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:18:01Z","timestamp":1793459881499,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K015338\/1"],"award-info":[{"award-number":["MR\/K015338\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["2013-9"],"award-info":[{"award-number":["2013-9"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Takeda UK Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20014"],"award-info":[{"award-number":["IS-BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["20189"],"award-info":[{"award-number":["20189"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.gim.2025.101502","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:14:29Z","timestamp":1750209269000},"page":"101502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gaucher disease type 3: Classification of the chronic neuronopathic variant informed by genotype in a phenotypically diverse cohort"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2623-5233","authenticated-orcid":false,"given":"Aim\u00e9e","family":"Donald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chakrapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vellodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.B.","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Banka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Santra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Geberhiwot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gim.2025.101502_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.gim.2025.101502_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lab.2004.03.013","article-title":"Mutations in the gene encoding cytosolic \u03b2-glucosidase in Gaucher disease","volume":"144","author":"Beutler","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.gim.2025.101502_bib3","author":"Gaucher","year":"1882","journal-title":"De l\u2019\u00c9pith\u00e9lioma Primitif de la Rate. Hypertrophie Idiopa- Thique de la Rate sans Leuc\u00e9mie"},{"issue":"3","key":"10.1016\/j.gim.2025.101502_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.gim.2025.101502_bib5","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jimd.12235","article-title":"The definition of neuronopathic Gaucher disease","volume":"43","author":"Schiffmann","year":"2020","journal-title":"J Inherit Metab Dis"},{"issue":"15","key":"10.1016\/j.gim.2025.101502_bib6","doi-asserted-by":"crossref","first-page":"e2119","DOI":"10.1212\/WNL.0000000000010605","article-title":"The natural history of type 2 Gaucher disease in the 21st century: a retrospective study","volume":"95","author":"Roshan Lal","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.gim.2025.101502_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ymgme.2021.06.009","article-title":"Throwing a spotlight on under-recognized manifestations of Gaucher disease: pulmonary involvement, lymphadenopathy and Gaucheroma","volume":"133","author":"Ramaswami","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gim.2025.101502_bib8","first-page":"81","article-title":"Imiglucerase in the treatment of Gaucher disease: a history and perspective","volume":"6","author":"Deegan","year":"2012","journal-title":"Drug Des Dev Ther"},{"issue":"3","key":"10.1016\/j.gim.2025.101502_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jnc.15492","article-title":"A new brain-penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease","volume":"159","author":"Fujii","year":"2021","journal-title":"J Neurochem"},{"issue":"20","key":"10.1016\/j.gim.2025.101502_bib10","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1021\/acschemneuro.0c00558","article-title":"Optimization of eliglustat-based glucosylceramide synthase inhibitors as substrate reduction therapy for Gaucher disease Type 3","volume":"11","author":"Wilson","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.gim.2025.101502_bib11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s13023-021-02034-6","article-title":"In-depth phenotyping for clinical stratification of Gaucher disease","volume":"16","author":"D\u2019Amore","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.gim.2025.101502_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.gim.2025.101502_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of miglustat in Gaucher\u2019s disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.gim.2025.101502_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jimd.12749","article-title":"Neuronopathic Gaucher disease: rare in the West, common in the East","volume":"47","author":"Goker-Alpan","year":"2024","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.gim.2025.101502_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13023-022-02378-7","article-title":"Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease","volume":"17","author":"Donald","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"suppl 3","key":"10.1016\/j.gim.2025.101502_bib16","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1007\/s10545-010-9176-5","article-title":"Pulmonary hemorrhage in type 3 Gaucher disease: a case report","volume":"33","author":"Vellodi","year":"2010","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.gim.2025.101502_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00442672","article-title":"Gaucher disease\u2014Norrbottnian type. Neurodevelopmental, neurological, and neurophysiological aspects","volume":"140","author":"Blom","year":"1983","journal-title":"Eur J Pediatr"},{"issue":"12","key":"10.1016\/j.gim.2025.101502_bib18","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1017\/S0022215113002521","article-title":"Middle-ear involvement in type I Gaucher\u2019s disease \u2013 a unique case","volume":"127","author":"Khan","year":"2013","journal-title":"J Laryngol Otol"},{"issue":"12","key":"10.1016\/j.gim.2025.101502_bib19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00234-018-2116-z","article-title":"Thalamic and dentate nucleus abnormalities in the brain of children with Gaucher disease","volume":"60","author":"Perucca","year":"2018","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.gim.2025.101502_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","article-title":"The clinical management of Type 2 Gaucher disease","volume":"114","author":"Weiss","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"10","key":"10.1016\/j.gim.2025.101502_bib21","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1212\/WNL.43.10.1993","article-title":"Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher\u2019s disease","volume":"43","author":"Patterson","year":"1993","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.gim.2025.101502_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymgme.2019.08.006","article-title":"Mutations, modifiers and epigenetics in Gaucher disease: blurred boundaries between simple and complex disorders","volume":"128","author":"Ryan","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.gim.2025.101502_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bcmd.2005.07.005","article-title":"Hematologically important mutations: Gaucher disease","volume":"35","author":"Beutler","year":"2005","journal-title":"Blood Cells Mol Dis"},{"issue":"26","key":"10.1016\/j.gim.2025.101502_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk1296","article-title":"The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1","volume":"10","author":"Gustavsson","year":"2024","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.gim.2025.101502_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/367850","article-title":"Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease","volume":"72","author":"Tayebi","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.gim.2025.101502_bib26","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/ajmg.a.63115","article-title":"The spectrum of neurological manifestations and genotype-phenotype correlation in Indian children with Gaucher disease","volume":"191","author":"Venkatachari","year":"2023","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.gim.2025.101502_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s44162-023-00011-0","article-title":"Egyptian Gaucher disease type 3 patients: a large cohort study spanning two decades","volume":"2","author":"El-Beshlawy","year":"2023","journal-title":"J Rare Dis"},{"issue":"5","key":"10.1016\/j.gim.2025.101502_bib28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10545-011-9347-z","article-title":"Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool","volume":"34","author":"Davies","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.gim.2025.101502_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2007.12.023","article-title":"Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease","volume":"153","author":"Goker-Alpan","year":"2008","journal-title":"J Pediatr"},{"issue":"24","key":"10.1016\/j.gim.2025.101502_bib30","doi-asserted-by":"crossref","first-page":"e2272","DOI":"10.1212\/WNL.0000000000008618","article-title":"Variation in cognitive function over time in Gaucher disease type 3","volume":"93","author":"Steward","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.gim.2025.101502_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s12311-012-0355-9","article-title":"Consensus paper: pathological role of the cerebellum in autism","volume":"11","author":"Fatemi","year":"2012","journal-title":"Cerebellum"},{"issue":"2","key":"10.1016\/j.gim.2025.101502_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0887-8994(87)90033-6","article-title":"Gaucher disease (type III): intellectual profile","volume":"3","author":"Erikson","year":"1987","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.gim.2025.101502_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00690463","article-title":"Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies","volume":"65","author":"Conradi","year":"1984","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.gim.2025.101502_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol Genet Metab"},{"issue":"7","key":"10.1016\/j.gim.2025.101502_bib35","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/brain\/awf168","article-title":"Adaptive modification of saccade amplitude in Parkinson\u2019s disease","volume":"125","author":"MacAskill","year":"2002","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.gim.2025.101502_bib36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000330671","article-title":"Directional asymmetries of saccadic hypometria in patients with early Parkinson\u2019s disease and unilateral symptoms","volume":"66","author":"Choi","year":"2011","journal-title":"Eur Neurol"},{"key":"10.1016\/j.gim.2025.101502_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clinph.2022.08.012","article-title":"Making saccades, fast and slow: the voluntary versus reflexive saccade systems in Parkinson\u2019s disease","volume":"143","author":"Terao","year":"2022","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.gim.2025.101502_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clinph.2022.07.505","article-title":"Medication adversely impacts visually guided eye movements in Parkinson\u2019s disease","volume":"143","author":"Munoz","year":"2022","journal-title":"Clin Neurophysiol"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025001492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025001492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:01:53Z","timestamp":1778943713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360025001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1098360025001492"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2025.101502","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaucher disease type 3: Classification of the chronic neuronopathic variant informed by genotype in a phenotypically diverse cohort","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2025.101502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"101502"}}